| 臺大學術典藏 |
2020-12-29T06:37:47Z |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Su T.-H.; Liu C.-J.; Lo Y.-C.; SZU-MIN HSIEH; Sheng W.-H.; Sun H.-Y.; Liu C.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2018-09-10T15:24:57Z |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study.
|
Chen-Hua Liu, Wang-Hui Sheng, Hsin-Yun Sun, Szu-Min Hsieh, Yi-Chun Lo, Chun-Jen Liu, Tung-Hung Su, Hung-Chih Yang, Wen-Chun Liu, Pei-Jer Chen, Ding-Shinn Chen, Chien-Ching Hung, Jia-Horng Kao; Liu, Chen-Hua;Sheng, Wang-Hui;Sun, Hsin-Yun;Hsieh, Szu-Min;Lo, Yi-Chun;Liu, Chun-Jen;Su, Tung-Hung;Yang, Hung-Chih;Liu, Wen-Chun;Chen, Pei-Jer;Chen, Ding-Shinn;Hung, Chien-Ching;Kao, Jia-Horng; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;孫幸筠;劉俊人;謝思民;陳培哲;盛望徽;洪健清; Chang, Tien-Jyun; Liu, Chen-Hua; HUNG-CHIH YANG; Sheng, Wang-Hui; CHUN-JEN LIU; Tseng, Hsing-Chi; Sun, Hsin-Yun; Liu, Meng-Wei; SZU-MIN HSIEH; PEI-JER CHEN; Chang, Yi-Cheng; Hsieh, Szu-Min; Hsieh, Meng-Lun; Lo, Yi-Chun; CHEN-HUA LIU; Liu, Chun-Jen; Chuang, Lee-Ming; DING-SHINN CHEN; TUNG-HUNG SU; Su, Tung-Hung; Yang, Hung-Chih; HSIN-YUN SUN; Liu, Wen-Chun; JIA-HORNG KAO; CHIEN-CHING HUNG; Chen, Pei-Jer; Chen, Ding-Shinn; Hung, Chien-Ching; Kao, Jia-Horng; ?????; ?i?H??; ?i??g; ?????? |
| 臺大學術典藏 |
2021-07-03T03:33:59Z |
Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 臺大學術典藏 |
2021-07-12T02:44:41Z |
Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu C.-H; | Huang C.-F; | Liu C.-J; | Dai C.-Y; | Huang J.-F; | Lin J.-W; | Liang C.-C; | Yang S.-S; | Lin C.-L; | Su T.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Chuang W.-L; | Kao J.-H; | Yu M.-L. |
| 臺大學術典藏 |
2021-09-04T06:11:25Z |
Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; JIA-HORNG KAO; Yu M.-L. |
| 臺大學術典藏 |
2022-01-24T09:31:34Z |
Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu C.-H.; Huang C.-F.; CHUN-JEN LIU; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 國立臺灣大學 |
2015 |
Peginterferon plus weight-based ribavirin for treatment-naive hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Huang, Jee-Fu; Lin, Jou-Wei; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, C.-H. and Huang, C.-F. and Liu, C.-J. and Dai, C.-Y. and Huang, J.-F. and Lin, J.-W. and Liang, C.-C. and Yang, S.-S. and Lin, C.-L. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Kao, J.-H. and Yu, M.-L.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;林昭維; Wu, Cho-Kai; Liu, Chen-Hua; HUNG-CHIH YANG; CHUN-JEN LIU; Su, Mao-Yuan; Huang, Chung-Feng; PEI-JER CHEN; Lee, Jen-Kuang; Liu, Chun-Jen; Dai, Chia-Yen; Chiang, Fu-Tien; CHEN-HUA LIU; Hwang, Juey-Jen; Huang, Jee-Fu; DING-SHINN CHEN; Lin, Jiunn-Lee; TUNG-HUNG SU; Lin, Jou-Wei; JIA-HORNG KAO; Chen, Jin-Jer; Liang, Cheng-Chao; Yang, Sheng-Shun; Liu, Fu-Tong; Lin, Chih-Lin; Tsai, Chia-Ti; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; ??????; ?L?T??; ?????; ??Z??; ?d????; ???礯; ?????? |
| 臺大學術典藏 |
2021-03-09T01:47:36Z |
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 臺大學術典藏 |
2021-05-24T07:20:34Z |
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
CHEN-HUA LIU; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 臺大學術典藏 |
2018-09-10T14:59:14Z |
Peginterferon α in the treatment of chronic hepatitis B
|
Tseng, T.-C.; Kao, J.-H.; Chen, D.-S.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:11:41Z |
Peginterferon α in the treatment of chronic hepatitis B
|
Tseng T.-C.; JIA-HORNG KAO; Chen D.-S. |
| 南台科技大學 |
2005-11 |
Pegradation of gaseous propanol under visible light irradiation using thermal nitrogen-plasma treated titanium dioxide nanotube
|
李友竹; C. M. Huang ; Y. C. M. Li ; J. C. Chung; G. T. Pan |
| 國家衛生研究院 |
2014-12 |
Pegylated arginine deiminase (ADI-PEG20) in relapsed/refractory and/or elder Acute Myeloid Leukemia: The preliminary result of phase II trial
|
Tsai, HJ;Wang, MC;Lin, SF;Chen, YP;Hsiao, HH;Kuo, CY;Chen, LT;Chen, TY |
| 國立成功大學 |
2014-12-06 |
Pegylated Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory and/or Elder Acute Myeloid Leukemia: The Preliminary Result of Phase II Trial
|
TTsai, Hui-Jen; Wang, Ming-Chung; Lin, Sheng-Fung; Chen, Ya-Ping; Hsiao, Hui-Hwa; Kuo, Ching-Yuan; Chen, Li-Tzong; Chen, Tsai-Yun |
| 國立成功大學 |
2015-06 |
Pegylated disintegrin exhibits more potent antithrombotic activity in vivo
|
Hsu, C-C; Chuang, W-J; Huang, T-F |
| 國立臺灣大學 |
2015 |
Pegylated disintegrin exhibits more potent antithrombotic activity in vivo
|
Hsu, C-C; Chuang, W-J; Huang, T-F; 黃德富 |
| 國立臺灣海洋大學 |
2014-03 |
Pegylated Gold Nanoparticles Induce Apoptosis in Human Chronic Myeloid Leukemia Cells
|
Y. S. Chu; E. Nazaretski; X. Huang; Y. Hwu; H. Yan; K. Lauer; R. Conley; N. Bouet; J. Zhou; W. Xu; D. Eom; D. Legnini; R. Harder; C.-H. Lin; Y.-S. Chen |
| 臺大學術典藏 |
2021-05-07T06:48:02Z |
Pegylated gold nanoparticles induce apoptosis in human chronic myeloid leukemia cells
|
Huang Y.-C.; Yang Y.-C.; KAI-CHIEN YANG; Shieh H.-R.; Wang T.-Y.; Hwu Y.; Chen Y.-J. |
| 國立臺灣大學 |
2011 |
Pegylated Guanidinylated Polyallylamine as Gene-Delivery Carrier
|
鍾易辰; 魏明鋒; 張富雄; 楊台鴻; CHUNG, YI-CHEN; WEI, MING-FENG; CHANG, FU-HSIUNG; YOUNG, TAI-HORNG |
| 臺大學術典藏 |
2020-01-21T06:05:56Z |
PEGylated guanidinylated polyallylamine as gene-delivery carrier
|
Chung Y.-C. ;Wei M.-F. ;Fu-Hsiung Chang ;Young T.-H.; Chung Y.-C.; Wei M.-F.; FU-HSIUNG CHANG; Young T.-H. |
| 中國醫藥大學 |
2011-09-10 |
PEGylated Herbal -loaded Nanoparticles for Cancer Therapy: Synthesis, Characterization, and Functionality
|
周志謂(Chih-Wei Chou) |
| 國家衛生研究院 |
2016-12-20 |
Pegylated IFN-alpha suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
|
Liu, WL;Yang, HC;Hsu, CS;Wang, CC;Wang, TS;Kao, JH;Chen, DS |
| 國立臺灣大學 |
2016 |
Pegylated IFN-alpha suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
|
Liu, Wei-Liang; Yang, Hung-Chih; Hsu, Ching-Sheng; Wang, Chih-Chiang; Wang, Tzu-San; Kao, Jia-Horng; Chen, Ding-Shinn; 陳定信; 高嘉宏; 楊宏志 |
| 臺大學術典藏 |
2018-09-10T15:34:51Z |
Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
|
Liu, Wei-Liang;Yang, Hung-Chih;Hsu, Ching-Sheng;Wang, Chih-Chiang;Wang, Tzu-San;Kao, Jia-Horng;Chen, Ding-Shinn; Liu, Wei-Liang; HUNG-CHIH YANG; DING-SHINN CHEN; Yang, Hung-Chih; Yang, Hung-Chih; JIA-HORNG KAO; Hsu, Ching-Sheng; Wang, Chih-Chiang; Wang, Chih-Chiang; Wang, Tzu-San; Wang, Tzu-San; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Ding-Shinn |
| 臺大學術典藏 |
2021-09-04T06:11:07Z |
Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
|
Liu W.-L.; Yang H.-C.; Hsu C.-S.; Wang C.-C.; Wang T.-S.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-07-12T02:44:37Z |
Pegylated IFN-�\ suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
|
Liu W.-L; | HUNG-CHIH YANG; | Hsu C.-S; | Wang C.-C; | Wang T.-S; | Kao J.-H; | Chen D.-S. |
| 國立臺灣大學 |
2009 |
Pegylated Interferon Alfa-2a Monotherapy for Hemodialysis Patients with Acute Hepatitis C
|
劉振驊; 梁程超; 劉俊人; 徐士哲; 陳世宜; 蔡宏斌; 洪培豪; 林昭維; 賴明陽; 陳培哲; 陳俊恆; 陳定信; 高嘉宏; LIU, CHEN-HUA; LIANG, CHENG-CHAO; LIU, CHUN-JEN; HSU, SHIH-JER; CHEN, SHIH-I; TSAI, HUNG-BIN; HUNG, PEIR-HAUR; LIN, JOU-WEI; LAI, MING-YANG; CHEN, PEI-JER; CHEN, JUN-HENG; CHEN, DING-SHINN; KAO, JIA-HORNG |
| 國立臺灣大學 |
2010 |
Pegylated Interferon Alfa-2a Monotherapy for Hemodialysis Patients with Acute Hepatitis C
|
劉振驊; 梁程超; 劉俊人; 林昭維; 陳世宜; 洪培豪; 蔡宏斌; 賴明陽; 陳培哲; 陳定信; 高嘉宏; LIU, CHEN-HUA; LIANG, CHENG-CHAO; LIU, CHUN-JEN; LIN, JOU-WEI; CHEN, SHIH-I; HUNG, PEIR-HAUR; TSAI, HUNG-BIN; LAI, MING-YANG; CHEN, PEI-JER; CHEN, DING-SHINN; KAO, JIA-HORNG |
| 臺大學術典藏 |
2021-05-24T07:20:50Z |
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C
|
CHEN-HUA LIU; Liang C.-C.; Liu C.-J.; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:41Z |
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:12:14Z |
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:31:58Z |
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C
|
Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2018-09-10T08:04:05Z |
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C.
|
Chun-Jen Liu;Pei-Jer Chen;Hung-Bin Tsai;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 中國醫藥大學 |
2009-09-27 |
Pegylated interferon alfa-2a therapy for HBeAg-negative chronic hepatitis B in Taiwan
|
賴學洲(Hsueh-Chou Lai); 澎成元(CY Peng); 蘇文邦(Wen-Pang Su); 莊伯恒(Po-Heng Chuang); 高榮達(Jung-Ta Kao); 周仁偉(Jen-Wei Chou); 賴學洲(Hsueh-Chou Lai) |
| 國立臺灣大學 |
2009 |
Pegylated Interferon Alpha-2a Plus Low-Dose Ribavirin for the Retreatment of Dialysis Chronic Hepatitis C Patients Who Relapsed from Prior Interferon Monotherapy
|
劉振驊; 梁程超; 劉俊人; 蔡宏斌; 洪培豪; 徐士哲; 陳世宜; 林昭維; 賴明陽; 陳俊恒; 陳培哲; 陳定信; 高嘉宏; LIU, CHEN-HUA; LIANG, CHENG-CHAO; LIU, CHUN-JEN; TSAI, HUNG-BIN; HUNG, PEIR-HAUR; HSU, SHIH-JER; CHEN, SHIH-I; LIN, JOU-WEI; LAI, MING-YANG; CHEN, JUN-HENG; CHEN, PEI-JER; CHEN, DING-SHINN; KAO, JIA-HORNG |
| 國立臺灣大學 |
2008 |
Pegylated Interferon Alpha-2a Versus Standard Interferon Alpha-2a for Treatment-Naive Dialysis Patients with Chronic Hepatitis C: A Randomised Study
|
劉振驊; 梁程超; 林昭維; 陳世宜; 蔡宏斌; 張繼森; 洪培豪; 劉俊人; 賴明陽; 陳俊恒; 陳培哲; 高嘉宏; 陳定信; LIU, CHEN-HUA; LIANG, CHENG-CHAO; LIN, JOU-WEI; CHEN, SHIH-I; TSAI, HUNG-BIN; CHANG, CHI-SEN; HUNG, PEIR-HAUR; LIU, CHUN-JEN; LAI, MING-YANG; CHEN, JUN-HENG; CHEN, PEI-JER; KAO, JIA-HORNG; CHEN, DING-SHINN |
| 國立臺灣大學 |
2008-04 |
Pegylated interferon alpha-2a versus standard interferon alpha-2a for treatment-naive dialysis patients with chronic hepatitis C: a randomised study.
|
Liu, CH; Liang, CC; Lin, JW; Chen, SI; Tsai, HB; Chang, CS; Hung, PH; Kao, JH; Liu, CJ; Lai, MY; Chen, JH; Chen, PJ; Kao, JH; Chen, DS. |
| 高雄醫學大學 |
2008 |
Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues.
|
余明隆;戴嘉言;黃志富;謝明彥;莊萬龍 ; Yu ML;Dai CY;Huang JF;Hsieh MY;Chuang WL. |
| 高雄醫學大學 |
2005 |
Pegylated Interferon in the Treatment of HBeAg-Positive Chronic Hepatitis B
|
莊萬龍 |
| 臺大學術典藏 |
2018-09-10T07:35:31Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu, C.-H.;Liang, C.-C.;Liu, C.-J.;Tsai, H.-B.;Hung, P.-H.;Hsu, S.-J.;Chen, S.-L.;Lin, J.-W.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-05-24T07:20:53Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
CHEN-HUA LIU; Liang C.-C.; Liu C.-J.; Tsai H.-B.; Hung P.-H.; Hsu S.-J.; Chen S.-L.; Lin J.-W.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:54Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tsai H.-B.; Hung P.-H.; Hsu S.-J.; Chen S.-L.; Lin J.-W.; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:12:27Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tsai H.-B.; Hung P.-H.; Hsu S.-J.; Chen S.-L.; Lin J.-W.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:32:03Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Tsai H.-B.; Hung P.-H.; Hsu S.-J.; Chen S.-L.; Lin J.-W.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 中國醫藥大學 |
2009-03-14 |
PEGYLATED INTERFERON α-2A THERAPY FOR HBEAG-NEGATIVE CHRONIC HEPATITIS B
|
賴學洲(Hsueh-Chou Lai); 彭成元(Cheng-Yuan Peng); 蘇文邦(Wen-Pang Su); 莊伯恒(Po-Heng Chuang); 高榮達(Jung-Ta Kao); 周仁偉(Jen-Wei Chou); 賴學洲(Hsueh-Chou Lai) |
| 臺大學術典藏 |
2021-07-03T03:35:05Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-na?ve dialysis patients with chronic hepatitis C: A randomised study
|
Liu C.-H.; Liang C.-C.; Lin J.-W.; Chen S.-I.; Tsai H.-B.; Chang C.-S.; Hung P.-H.; Kao J.-H.; Liu C.-J.; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:32:09Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-na?ve dialysis patients with chronic hepatitis C: A randomised study
|
Liu C.-H.; Liang C.-C.; Lin J.-W.; Chen S.-I.; Tsai H.-B.; Chang C.-S.; Hung P.-H.; Kao J.-H.; CHUN-JEN LIU; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:12:36Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-na?ve dialysis patients with chronic hepatitis C: A randomised study
|
Liu C.-H.; Liang C.-C.; Lin J.-W.; Chen S.-I.; Tsai H.-B.; Chang C.-S.; Hung P.-H.; JIA-HORNG KAO; Liu C.-J.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-05-24T07:20:55Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: A randomised study
|
CHEN-HUA LIU; Liang C.-C.; Lin J.-W.; Chen S.-I.; Tsai H.-B.; Chang C.-S.; Hung P.-H.; Kao J.-H.; Liu C.-J.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Kao J.-H.; Chen D.-S. |
